[Role of influenza virus sialidase].
Takahashi
Tadanobu
T
Department of Biochemistry, University of Shizuoka, School of Pharmaceutical Sciences, COE Program in the 21St Century, CREST, 52-1 Yada Shizuoka 422-8526, Japan.
Suzuki
Yasuo
Y
Suzuki
Takashi
T
D000081:Acetamides; D000998:Antiviral Agents; D017209:Apoptosis; D053148:Caspase 3; D020169:Caspases; D004196:Disease Outbreaks; D006146:Guanidines; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007251:Influenza, Human / Q000453:epidemiology / Q000276:immunology / Q000473:pathology / Q000821:virology; D009439:Neuraminidase / Q000037:antagonists & inhibitors / Q000502:physiology; D009975:Orthomyxoviridae / Q000201:enzymology*; D053139:Oseltamivir; D011714:Pyrans; D012794:Sialic Acids; D014759:Viral Envelope Proteins / Q000378:metabolism; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; D011714:Pyrans; D012794:Sialic Acids; D014759:Viral Envelope Proteins; D053139:Oseltamivir; D009439:Neuraminidase; C505407:CASP3 protein, human; D053148:Caspase 3; D020169:Caspases; D053243:Zanamivir